SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Edouard Bardou-Jacquet, Pierre Brissot, Diagnostic Evaluation of Hereditary Hemochromatosis (HFE and Non-HFE), Hematology/Oncology Clinics of North America, 2014, 28, 4, 625

    CrossRef

  2. You have free access to this content2
    Darrell H. G. Crawford, Hereditary hemochromatosis types 1, 2, and 3, Clinical Liver Disease, 2014, 3, 5
  3. 3
    Philippe Bianga Katchunga, Marius Baguma, Jean-René M‘Buyamba-Kabangu, Jan Philippé, Michel P. Hermans, Joris Delanghe, Ferroportin Q248H mutation, hyperferritinemia and atypical type 2 diabetes mellitus in South Kivu, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2013, 7, 2, 112

    CrossRef

  4. 4
    Agustin Castiella, Jose M Alústiza, Eva Zapata, José I Emparanza, Is MRI becoming the new gold standard for diagnosing iron overload in hemochromatosis and other liver iron disorders?, Imaging in Medicine, 2013, 5, 6, 515

    CrossRef

  5. 5
    Simon Hazeldine, Debbie Trinder, John K. Olynyk, Non-Hfe Iron Overload: Is Phlebotomy the Answer?, Current Hepatitis Reports, 2013, 12, 1, 20

    CrossRef

  6. 6
    R. Ramakrishna, S. Gupta, K. Sarathy, A. Bowen, Phenotypic and clinical manifestations of compound heterozygous genetic haemochromatosis (CHGH): a non-invasive approach to clinical management, Internal Medicine Journal, 2013, 43, 3
  7. 7
    Kaveh Hoda, Christopher L. Bowlus, Thomas W. Chu, Jeffrey R. Gruen, Emery and Rimoin's Principles and Practice of Medical Genetics, 2013,

    CrossRef

  8. 8
    I. Ortiz Polo, J.M. Paredes Arquiola, A. López Serrano, E. Moreno-Osset, Hemocromatosis: etiopatogenia, diagnóstico y estrategia terapéutica, Medicine - Programa de Formación Médica Continuada Acreditado, 2012, 11, 19, 1153

    CrossRef

  9. 9
    Kathryn L. Maxwell, Kris V. Kowdley, Metals and the liver, Current Opinion in Gastroenterology, 2012, 28, 3, 217

    CrossRef

  10. You have free access to this content10
    A. Siddique, K. V. Kowdley, Review article: the iron overload syndromes, Alimentary Pharmacology & Therapeutics, 2012, 35, 8
  11. 11
    Itty M. Nadakkavukaran, Eng K. Gan, John K. Olynyk, Screening for hereditary haemochromatosis, Pathology, 2012, 44, 2, 148

    CrossRef

  12. 12
    Ángel Cosme, Evelia Ojeda, Luis Bujanda, María Dolores De Juan, José María Alustiza, Agustín Castiella, Eva Zapata, Alejandra Gómez, Características clínicas y evolutivas de una familia con hemocromatosis hereditaria tipo 1, Gaceta Médica de Bilbao, 2011, 108, 2, 42

    CrossRef

  13. 13
    Bruce R. Bacon, Paul C. Adams, Kris V. Kowdley, Lawrie W. Powell, Anthony S. Tavill, Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases, Hepatology, 2011, 54, 1
  14. 14
    Soo Aleman, Sanam Endalib, Per Stål, Lars Lööf, Stefan Lindgren, Hanna Sandberg-Gertzén, Sven Almer, Sigvard Olsson, Åke Danielsson, Sven Wallerstedt, Rolf Hultcrantz, Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population, Scandinavian Journal of Gastroenterology, 2011, 46, 9, 1118

    CrossRef

  15. 15
    Takashi Maeda, Tsuyoshi Nakamaki, Bungo Saito, Hidetoshi Nakashima, Hirotsugu Ariizumi, Kouji Yanagisawa, Ai Hattori, Yasuaki Tatsumi, Hisao Hayashi, Kenshi Suzuki, Shigeru Tomoyasu, Hemojuvelin hemochromatosis receiving iron chelation therapy with deferasirox: improvement of liver disease activity, cardiac and hematological function, European Journal of Haematology, 2011, 87, 5
  16. 16
    Haris Riaz, Talha Riaz, Muhammad Khan, Sina Aziz, Faizan Ullah, Anis Rehman, Qandeel Zafar, Abdul Kazi, Serum ferritin levels, socio-demographic factors and desferrioxamine therapy in multi-transfused thalassemia major patients at a government tertiary care hospital of Karachi, Pakistan, BMC Research Notes, 2011, 4, 1, 287

    CrossRef

  17. 17
    Roman Mayr, Andreas R. Janecke, Melanie Schranz, William J.H. Griffiths, Wolfgang Vogel, Antonello Pietrangelo, Heinz Zoller, Ferroportin disease: A systematic meta-analysis of clinical and molecular findings, Journal of Hepatology, 2010, 53, 5, 941

    CrossRef

  18. 18
    Armin Finkenstedt, Elisabeth Wolf, Elmar Höfner, Bethina Isasi Gasser, Sylvia Bösch, Rania Bakry, Marc Creus, Christian Kremser, Michael Schocke, Milan Theurl, Patrizia Moser, Melanie Schranz, Guenther Bonn, Werner Poewe, Wolfgang Vogel, Andreas R. Janecke, Heinz Zoller, Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation, Journal of Hepatology, 2010, 53, 6, 1101

    CrossRef

  19. 19
    Antonello Pietrangelo, Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment, Gastroenterology, 2010, 139, 2, 393

    CrossRef

  20. 20
    P. Richette, C. Eymard, M. Deberg, D. Vidaud, C. de Kerguenec, D. Valla, E. Vicaut, T. Bardin, Y. Henrotin, Increase in type II collagen turnover after iron depletion in patients with hereditary haemochromatosis, Rheumatology, 2010, 49, 4, 760

    CrossRef

  21. 21
    Wei Wang, Mary Ann Knovich, Lan G. Coffman, Frank M. Torti, Suzy V. Torti, Serum ferritin: Past, present and future, Biochimica et Biophysica Acta (BBA) - General Subjects, 2010, 1800, 8, 760

    CrossRef

  22. 22
    Agustin Castiella, Eva Zapata, Maria Dolores De Juan, Pedro Otazua, Javier Fernandez, Leire Zubiaurre, Jose A. Arriola, Significance of H63D homozygosity in a Basque population with hemochromatosis, Journal of Gastroenterology and Hepatology, 2010, 25, 7
  23. 23
    Agustin Castiella, Eva Zapata, Pedro Otazua, Hemochromatosis: Platelets and aspartate aminotransferase are useful high-degree fibrosis marker, Hepatology, 2009, 49, 5
  24. 24
    Jacob Alexander, Kris V Kowdley, HFE-associated hereditary hemochromatosis, Genetics in Medicine, 2009, 11, 5, 307

    CrossRef

  25. 25
    Darrell H. G. Crawford, Grant A. Ramm, Reply: Utility of platelets and aspartate aminotransferase vs serum ferritin and serum hyaluronic acid as markers of cirrhosis in hemochromatosis, Hepatology, 2009, 49, 5
  26. 26
    Darrell H. G. Crawford, Therese L. Murphy, Louise E. Ramm, Linda M. Fletcher, Andrew D. Clouston, Gregory J. Anderson, V. Nathan Subramaniam, Lawrie W. Powell, Grant A. Ramm, Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis, Hepatology, 2009, 49, 2
  27. 27
    Esther M.G. Jacobs, Jan C.M. Hendriks, Cees Th.B.M. van Deursen, Herman G. Kreeftenberg, Richard A. de Vries, Joannes J.M. Marx, Anton F.H. Stalenhoef, André L.M. Verbeek, Dorine W. Swinkels, Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: The HEmochromatosis FAmily Study, Journal of Hepatology, 2009, 50, 1, 174

    CrossRef

  28. 28
    M. Ruivard, Surcharges en fer d’origine génétique et hépatosidérose dysmétabolique, La Revue de Médecine Interne, 2009, 30, 1, 35

    CrossRef

  29. 29
    C. J. CROOKS, J. WEST, M. SOLAYMANI-DODARAN, T. R. CARD, The epidemiology of haemochromatosis: a population-based study, Alimentary Pharmacology & Therapeutics, 2009, 29, 2
  30. 30
    Marnie J. Wood, Richard Skoien, Lawrie W. Powell, The global burden of iron overload, Hepatology International, 2009, 3, 3, 434

    CrossRef

  31. 31
    Enrico Rossi, John K Olynyk, Gary P Jeffrey, Clinical penetrance of C282Y homozygousHFEhemochromatosis, Expert Review of Hematology, 2008, 1, 2, 205

    CrossRef

  32. 32
    Domenico Girelli, Ivana De Domenico, Claudia Bozzini, Natascia Campostrini, Fabiana Busti, Annalisa Castagna, Nadia Soriani, Laura Cremonesi, Maurizio Ferrari, Romano Colombari, Diane McVey Ward, Jerry Kaplan, Roberto Corrocher, Clinical, pathological, and molecular correlates in ferroportin disease: A study of two novel mutations, Journal of Hepatology, 2008, 49, 4, 664

    CrossRef

  33. 33
    X. Adhoute, J. Foucher, D. Laharie, E. Terrebonne, J. Vergniol, L. Castéra, B. Lovato, E. Chanteloup, W. Merrouche, P. Couzigou, V. de Lédinghen, Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: A prospective study, Gastroentérologie Clinique et Biologique, 2008, 32, 2, 180

    CrossRef

  34. 34
    Paul C. Adams, Natural History of Hemochromatosis: Heading Down the Up Escalator?, Gastroenterology, 2008, 135, 6, 1855

    CrossRef

  35. 35
    J. Waalen, V. J. Felitti, T. Gelbart, E. Beutler, Response: Screening for treatable disease is better than just screening for hemochromatosis, Blood, 2008, 111, 7, 3897

    CrossRef

  36. 36
    J. Waalen, V. J. Felitti, T. Gelbart, E. Beutler, Screening for hemochromatosis by measuring ferritin levels: a more effective approach, Blood, 2008, 111, 7, 3373

    CrossRef

  37. 37
    P. C. ADAMS, D. M. REBOUSSIN, J. C. BARTON, R. T. ACTON, M. SPEECHLEY, C. LEIENDECKER-FOSTER, R. MEENAN, L. PASSMORE, C. E. MCLAREN, G. D. MCLAREN, V. GORDEUK, F. DAWKINS, J. H. ECKFELDT, Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study, International Journal of Laboratory Hematology, 2008, 30, 4
  38. 38
    Paul C Adams, James C Barton, Haemochromatosis, The Lancet, 2007, 370, 9602, 1855

    CrossRef

  39. 39
    Antonello Pietrangelo, Hemochromatosis: An endocrine liver disease, Hepatology, 2007, 46, 4
  40. 40
    James C. Barton, Ronald T. Acton, Catherine Leiendecker-Foster, Laura Lovato, Paul C. Adams, Gordon D. McLaren, John H. Eckfeldt, Christine E. McLaren, David M. Reboussin, Victor R. Gordeuk, Mark R. Speechley, Jacob A. Reiss, Richard D. Press, Fitzroy W. Dawkins, HFEC282Y Homozygotes Aged 25–29 Years at HEIRS Study Initial Screening, Genetic Testing, 2007, 11, 3, 269

    CrossRef

  41. 41
    Y. Gandon, D. Olivié, C. Juhel, T. Rohou, C. Aubé, Hépatopathies de surcharge et cirrhose, EMC - Radiologie et imagerie médicale - Abdominale - Digestive, 2006, 1, 1, 1

    CrossRef

  42. 42
    Paul C. Adams, Leah Passmore, Subrata Chakrabarti, David M. Reboussin, Ronald T. Acton, James C. Barton, Gordon D. McLaren, John H. Eckfeldt, Fitzroy W. Dawkins, Victor R. Gordeuk, Emily L. Harris, Catherine Leiendecker–Foster, Elaine Gossman, Phyliss Sholinsky, Liver Diseases in the Hemochromatosis and Iron Overload Screening Study, Clinical Gastroenterology and Hepatology, 2006, 4, 7, 918

    CrossRef

  43. 43
    P. C. ADAMS, Review article: the modern diagnosis and management of haemochromatosis, Alimentary Pharmacology & Therapeutics, 2006, 23, 12
  44. 44
    John K. Olynyk, Timothy G. St. Pierre, Robert S. Britton, Elizabeth M. Brunt, Bruce R. Bacon, Duration of Hepatic Iron Exposure Increases the Risk of Significant Fibrosis in Hereditary Hemochromatosis: A New Role for Magnetic Resonance Imaging, The American Journal of Gastroenterology, 2005, 100, 4, 837

    CrossRef

  45. 45
    Agustin Castiella, Jose I. Emparanza, External Validation for Fibrosis Predicting Index in Hereditary Hemochromatosis, The American Journal of Gastroenterology, 2005, 100, 10, 2366

    CrossRef

  46. 46
    Paul C. Adams, David M. Reboussin, James C. Barton, Christine E. McLaren, John H. Eckfeldt, Gordon D. McLaren, Fitzroy W. Dawkins, Ronald T. Acton, Emily L. Harris, Victor R. Gordeuk, Catherine Leiendecker-Foster, Mark Speechley, Beverly M. Snively, Joan L. Holup, Elizabeth Thomson, Phyliss Sholinsky, Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population, New England Journal of Medicine, 2005, 352, 17, 1769

    CrossRef

  47. 47
    Paul C Adams, Screening for haemochromatosis—producing or preventing illness?, The Lancet, 2005, 366, 9482, 269

    CrossRef

  48. 48
    Patricia Aguilar-Martinez, Jean-Francois Schved, Pierre Brissot, The Evaluation of Hyperferritinemia: An Updated Strategy Based on Advances in Detecting Genetic Abnormalities, The American Journal of Gastroenterology, 2005, 100, 5, 1185

    CrossRef

  49. 49
    Jean-Claude Trinchet, Véronique Grando-Lemaire, Diagnostic de cirrhose, Gastroentérologie Clinique et Biologique, 2004, 28, 5, 121

    CrossRef

  50. 50
    Nezam H. Afdhal, David Nunes, Evaluation of Liver Fibrosis: A Concise Review, The American Journal of Gastroenterology, 2004, 99, 6, 1160

    CrossRef

  51. 51
    Paul C Adams, Haemochromatosis, European Journal of Gastroenterology & Hepatology, 2004, 16, 9, 857

    CrossRef

  52. 52
    Paul C. Adams, Hemochromatosis, Clinics in Liver Disease, 2004, 8, 4, 735

    CrossRef

  53. 53
    Y. Gandon, D. Olivié, C. Juhel, T. Rohou, C. Aubé, Hépatopathies de surcharge et cirrhose, EMC - Radiologie, 2004, 1, 6, 665

    CrossRef

  54. 54
    Aftab Ala, Michael L. Schilsky, Inherited metabolic liver disease, Current Opinion in Gastroenterology, 2004, 20, 3, 198

    CrossRef

  55. 55
    William M.C. Rosenberg, Michael Voelker, Robert Thiel, Michael Becka, Alastair Burt, Detlef Schuppan, Stefan Hubscher, Tania Roskams, Massimo Pinzani, Michael J.P. Arthur, Serum markers detect the presence of liver fibrosis: A cohort study, Gastroenterology, 2004, 127, 6, 1704

    CrossRef

  56. 56
    E. Cadet, D. Capron, A. S. Perez, S. N. Crépin, S. Arlot, J.-P. Ducroix, M. Dautréaux, P. Fardellone, P. Leflon, A. T. Merryweather-Clarke, K. J. Livesey, J. J. Pointon, P. Rose, J. Harcourt, J. Emery, J. M. Sueur, R. Feyt, K. J. H. Robson, J. Rochette, A targeted approach significantly increases the identification rate of patients with undiagnosed haemochromatosis, Journal of Internal Medicine, 2003, 253, 2
  57. 57
    Kevin M. Korenblat, Michael L. Schilsky, Inherited metabolic liver disease, Current Opinion in Gastroenterology, 2003, 19, 3, 194

    CrossRef

  58. 58
    Adriano Reuben, Just a second, Hepatology, 2003, 38, 5
  59. 59
    Lachlan RO Ayres, Vanoo Jayasekeran, John K Olynyk, Genotype–Phenotype Relationship in Hereditary Hemochromatosis, eLS,
  60. 60
    Antonello Pietrangelo, Hemochromatosis,
  61. 61
    Gary P Jeffrey, Paul C Adams, Hemochromatosis,
  62. 62
    Paul Adams, Iron Overload States,